References
- Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since. 1988. Analysis of the European Cancer Observatory. Eur J Cancer 2015;51(9):1164-87
- Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009;374(9688):477-90
- McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11(11):664-74
- Bali CD, Lianos GD, Roukos DH. Gastric cancer guidelines and genome differences between Japan and the west. Future Oncol 2013;9(8):1053-6
- Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357(18):1810-20
- NCCN (National Comprehensive Cancer Network). National Comprehensive Cancer Network Guidelines 2012. Available from: www.nccn.org/professionals/physician_gls/f_guidelines.asp#site
- Rolfo C, Bronte G, Sortino G, et al. The role of targeted therapy for gastrointestinal tumors. Expert Rev Gastroenterol Hepatol 2014;8(8):875-85
- Matsuoka T, Yashiro M. Recent advances in the HER2 targeted therapy of gastric cancer. World J Clin Cases 2015;3(1):42-51
- Watson IR, Takahashi K, Futreal PA, Chin L. Emerging patterns of somatic mutations in cancer. Nat Rev Genet 2013;14(10):703-18
- Hudler P. Genetic aspects of gastric cancer instability. ScientificWorldJournal 2012;2012:761909
- Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014;505(7484):495-501
- Yamamoto H, Watanabe Y, Maehata T, et al. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. World J Gastroenterol 2014;20(14):3927-37
- Liang H, Kim YH. Identifying molecular drivers of gastric cancer through next-generation sequencing. Cancer Lett 2013;340(2):241-6
- Catalogue of somatic mutations in cancer (COSMIC). Available from: http://cancer.sanger.ac.uk/cosmic
- Wang K, Kan J, Yuen ST, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 2011;43:1219-23
- Zang ZJ, et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012;44:570-4
- Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 2014;46(6):573-82
- Wong SS, Kim KM, Ting JC, et al. Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing. Nat Commun 2014;5:5477
- Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366(10):883-92
- Wang Y, Waters J, Leung ML, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014;512(7513):155-60
- Murtaza M, Dawson SJ, Tsui DW, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013;497:108-12
- Lianos GD, Mangano A, Kouraklis G, Roukos DH. Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker. Biomark Med 2014;8(5):629-32
- Lianos GD, Mangano A, Cho WC, et al. Circulating tumor DNA: new horizons for improving cancer treatment. Future Oncol 2015;11(4):545-8
- Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513(7517):202-9